CVS Health (CVS) announced Thursday that CVS Pharmacy locations in Massachusetts are now offering hormonal contraceptive prescribing services. Patients interested in receiving a birth control prescription can be evaluated by a CVS pharmacist and, if clinically eligible, receive a prescription for birth control.The new birth control prescribing service at CVS Pharmacy will help to close this gap and provide Massachusetts patients with convenient and affordable access to care when and where they need it.Hormonal contraceptive prescribing was authorized as part of the Massachusetts 2024 State Budget, which was signed in August 2023 and was co-sponsored by State Senator Michael Moore and State Representatives Christine Barber and Lindsay Sabadosa..

CVS Health（CVS）周四宣布，位于马萨诸塞州的CVS药房目前正在提供激素避孕药处方服务。有兴趣接受节育处方的患者可以由CVS药剂师进行评估，如果临床符合条件，可以接受节育处方。CVS药房新推出的节育处方服务将有助于缩小这一差距，并为马萨诸塞州患者提供方便且负担得起的护理。激素避孕药处方是马萨诸塞州2024年州预算的一部分，该预算于2023年8月签署，由州参议员迈克尔·摩尔和州众议员克里斯蒂娜·巴伯和林赛·萨巴多萨共同赞助。。

Patients, 18 and older, interested in birth control can visit any Massachusetts CVS Pharmacy location and ask for a birth control consultation with a pharmacist. The consultation will cost $39, regardless of whether medication is prescribed, which can be covered by HSA or FSA funds.All the nearly 400 CVS Pharmacy locations in Massachusetts are offering birth control prescribing.

18岁及以上对节育感兴趣的患者可以访问马萨诸塞州CVS的任何药房，并向药剂师寻求节育咨询。无论是否开具药物，咨询费用均为39美元，可由HSA或FSA基金支付。马萨诸塞州近400家CVS药房都在提供节育处方。

The service is also offered at CVS Pharmacy locations in California, Hawaii, Idaho, Michigan, Minnesota, Montana, Nebraska, South Dakota, Washington, and Wisconsin. For comments and feedback contact: editorial@rttnews.comBusiness News.

该服务也在加利福尼亚州、夏威夷州、爱达荷州、密歇根州、明尼苏达州、蒙大拿州、内布拉斯加州、南达科他州、华盛顿州和威斯康星州的CVS药房提供。如需评论和反馈，请联系：editorial@rttnews.comBusiness新闻。

Biotech Stocks Facing FDA Decision In August 2024

2024年8月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision In June 2024

2024年6月美国食品和药物管理局决定生物技术股

Biotech Stocks Facing FDA Decision In April 2024

2024年4月美国食品和药物管理局（FDA）决定生物技术股